Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets

Drug Delivery

Volumn 13, Issue 4, 2006, Pages 277-285

  Varshosaz, Jaleh ^a   Tavakoli, N ^a   Roozbahani, F ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ciprofloxacin; Extended Release Tablets; Floatation; Mucoadhesive

Indexed keywords

BICARBONATE; CARBOXYMETHYLCELLULOSE; CIPROFLOXACIN; CITRIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; POLYACRYLIC ACID; POLYMETHACRYLIC ACID;

ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; EFFERVESCENT TABLET; GASTROINTESTINAL ABSORPTION; IN VITRO STUDY; PRIORITY JOURNAL; TABLET FORMULATION;

ACRYLIC RESINS; ANTI-INFECTIVE AGENTS; CARBOXYMETHYLCELLULOSE; CHEMISTRY, PHARMACEUTICAL; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; METHYLCELLULOSE; POLYMETHACRYLIC ACIDS; SOLUBILITY; TABLETS;

EID: 33646676056     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500395106     Document Type: Article

References (42)

1. Ahuja, A., Khar, R. K., and Ali, J. 1997. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 23(5):489-515.
2. Alvisi, V., Gasparetoo, A., Dentale, A., et al., 1996. Bioavailability of a controlled release formulation of ursodeoxycholic acid in man. Drugs Exp. Clin. Res. 22:23-29.
3. Banakar, U. V. 1992. Pharmaceautical Dissolution Testing, 1st ed. New York: Marcel Dekker. 191-194.
4. Baumgartner, S., Kristl, J., Vrecer, F., Vodopivec, P., and Zorko, B. 2000. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 195:125-135.
5. Bechgaard, H., and Ladefoged, K. 1978. Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J. Pharm. Pharmacol. 30:690-692.
6. Chickering III, D. E., and Mathiowitz, E. 1999. Definitions, mechanisms and theories of bioadhesion, In Bioadhesive Drug Delivery Systems. Fundamental, Novel approaches, and Development, eds. Mathiowitz, E., Chickering III, D.E., and Lehr, C.M. New York: Marcel Dekker, 1-8.
7. Chitnis, V. S., Malshe, V. S., and Lalla, J. K. 1991. Bioadhesive polymersynthesis, evaluation and application in controlled release tablets. Drug Dev. Ind. Pharm. 17(6):879-892.
8. Chng, H. S., Park, H., Kelly, P., and Robinson, J. R. 1985. Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling water-insoluble bioadhesive polymers. J. Pharm. Sci. 74:399-405.
9. Chueh, H. R., Zia, H., and Rhodes, C. T. 1995. Optimization of sotalol and bioadhesive extended-release tablet formulations. Drug Dev. Ind. Pharm. 21(15):1725-1747.
10. Dave, B. S., Amin, A. F., and Patel, M. M. 2004. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS Pharm. Sci. Tech. 5(2): Article 34.
11. Davis, S. S., Stockwell, A. F., Taylor, M. J., et al., 1986. The effect of density on gastric emptying of single and multiple-unit dosage forms. Pharm. Res. 3:208-213.
12. Deshpande, A. A., Shah, N. H., Rhodes, C. T., and Malick, W. 1997. Development of a novel controlled-release system for gastric retention. Pharm. Res. 14:815-819.
13. Dortung, B., Ozer, L., and Uyanik, N. 1998. Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev. Ind. Pharm. 24(3):281-288.
14. Gan-Lin, C., and Wei-Hua, H. 1998. In vitro performance of floating sustained-release capsule of verapamil. Drug Dev. Ind. Pharm. 24(11):1067-1072.
15. 2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design. Drug Dev. Ind. Pharm. 28(1):77-87.
16. Harder, S., Fuhr, U., Beermann, D., and Staib, A. H. 1990. Ciprofloxacin absorption in different regions of the human gastrointestinal tract: investigations with the hf-capsule. Br. J. Clin. Pharmacol. 30:35-39.
17. Huneault, L. M., Lussier, B., Dubreuil, P., Chouinard, L., and Desevaux, C. 2004. Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants. J. Orthop. Res. 22(6):1351-1357.
18. Jikia, D., Chkhaidze, N., Imedashvili, E., et al. 2005. The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin. Exp. Dermatol. 30(1):23-26.
19. Kadry, A. A., Al-Suwayeh, S., A., Abd-Allah, A. R., and Bayomi, M. A. 2004. Treatment of experimental osteomyelitis by liposomal antibiotics. J. Antimicrob. Chemother. 54(6): 1103-1108.
20. Korsmeyer, R. W., and Peppas, N. A. 1983. Macromolecular and modeling aspects of swelling controlled systems. In Controlled Release Delivery Systems, eds. Roseman, T.J., and Mansdorf, S.Z. New York: Marcel Dekker, 77-90.
21. Li, S., Lin, S., Daggy, B. P., et al. 2002. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm. 28(7):783-793.
22. Li, S., Lin, S., Daggy, B. P., et al. 2003. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int. J. Pharm. 253:13-22.
23. Mamajek, R. C., Moyer, E. S. 1980. Drug-dispensing device and method. US Patent 4, 207, 890.
24. Mitchell, K., Ford, J. L., Armstrong, D. J., et al. 1993. The influence of concentration on the release of drugs from gels a matrices controlling Methocel. Int. J. Pharm. 100:155-163.
25. Muller-Lissner, S. A., and Blum, A. L. 1981. The effect of specific gravity and eating on gastric emptying of slow-release capsules. New Engl. J. Med. 304:1365-1366.
26. Parodi, B., Russo, E., Caviglioli, G., et al. 1996. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev. Ind. Pharm. 22(5):445-450.
27. Peppas, N. A. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60:110-111.
28. Peppas, N. A., and Wright, S. L. 1998. Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid). Eur. J. Pharm. Biopharm. 46:15-29.
29. Ponchel G., and Irache J. M. 1998. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Del. Rev. 34:191-219.
30. Ritschel, W. A. 1991. Targeting in the gastrointestinal tract: new approaches, Metods Find. Exp. Clin. Pharmacol. 13:313-316.
31. Rouge, N., Buri, P., and Doelker, E. 1996. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 136:117-139.
32. Rubinstein, A., and Friend, D. R. 1994. Specific delivery to the gastrointestinal tract. In Polymeric Site-Specific Pharmacotherapy, ed. Domb, A. J. Chichester: Wiley, 283-285.
33. Shah, N., Zhang, G., Apelian, V., Zeng, et al., 1993. Prediction of drug release from hydroxypropyl methylcellulose (HPMC) matrices: effect of polymer concentration. Pharm. Res. 10:1693-1695.
34. Siepmann, J., Streuble, A., and Peppas, N. A. 2002. Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model. Pharm. Res. 19:306-314.
35. Singh, B. N., and Kim, K. H. 2000. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 63:235-259.
36. Streubel, A., Siepmann, J., and Bodmeier, R. 2003. Floating matrix tablets based on low-density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 18(1):37-45.
37. Talan, D. A , Naber, K. G., Palou, J., and Elkharrat, D. 2004a. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Int. J. Antimicrob. Agents 23 Suppl 1:S54-S66.
38. Talan, D. A., Klimberg, I. W., Nicolle, L. E., et al. 2004b. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J. Urol. 171(2 Pt 1):734-739.
39. Urquhart, J., and Theeuwes, F. 1984. Drug delivery system comprising a reservoir containing a plurality of tiny pills, U.S. patent 4, 434, 153, February 28.
40. Wilson, C. G., and Washington, N. 1989. The stomach: its role in oral drug delivery. In Physiological Pharmaceutics: Biological Barriers to Drug Absorption, ed. Rubinstein, M. H. Chichester: Ellis Horwood, 47-70.
41. Yang, L., and Fassihi, R. 1997. Examination of drug solubility, polymer types, hydrodynamics and loading dose on drug release behaviour from a triple-layer asymmetric configuration delivery system. Int. J. Pharm. 155:219-229.
42. Yang, L., Eshraghi, J., and Fassihi, R. 1999. A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J. Control. Rel. 57:215-222.